phenoxybenzamine hydrochloride
NDC 16571-874, phenoxybenzamine hydrochloride, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-874
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204551
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-874 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PHENOXYBENZAMINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-874-01 | 16571087401 | 100 CAPSULE in 1 BOTTLE (16571-874-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1d2108fa-4352-4f3f-9314-732ed8b6394c
Use it
Look up 16571-874 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-874 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-874. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.